Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Individual RNA-seq for different prostate cancer cells and Lucap35CR PDX treated by SR8278,JQ1,AZD5153,ENZ or by FOXA1 and NR1D1 gene knockdown or NR1D1 overexpression.

ABSTRACT: Individual RNA-seq for different prostate cancer cells and Lucap35CR PDX treated by SR8278,JQ1,AZD5153,ENZ or by FOXA1 and NR1D1 gene knockdown or NR1D1 overexpression.

PROVIDER: PRJNA1082794 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR28200147_1.fastq.gz	Fastqsanger.gz
	SRR28200147_2.fastq.gz	Fastqsanger.gz
	SRR28200148_1.fastq.gz	Fastqsanger.gz
	SRR28200148_2.fastq.gz	Fastqsanger.gz
	SRR28200149_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 52

Similar Datasets

Individual RNA-seq for different prostate cancer cells and Lucap145.2 PDX treated by JQ1, AZD5153,ENZ or by FOXA1 and BRD4 gene knockdown

Project description:Individual RNA-seq for different prostate cancer cells and Lucap145.2 PDX treated by JQ1, AZD5153,ENZ or by FOXA1 and BRD4 gene knockdown

| PRJNA1104164 | ENA

Individual RNA-seq for different prostate cancer cells and Lucap35CR PDX treated by SR8278,JQ1,AZD5153,ENZ or by FOXA1 and NR1D1 gene knockdown or NR1D1 overexpression.

Project description:Gene expression profile of different prostate cancer PDX tumor, and cell models to study tumorigenic programs.

2024-09-25 | GSE260725 | GEO

Individual RNA-seq for different prostate cancer cells and Lucap145.2 PDX treated by JQ1, AZD5153,ENZ or by FOXA1 and BRD4 gene knockdown

Project description:Gene expression profile of different prostate cancer PDX tumor, and cell models to study tumorigenic programs.

2024-10-23 | GSE265762 | GEO

Transcriptional changes induced by Brd4 inhibitor, AZD5153, in cancer cell lines

Project description:We sequenced mRNA from 12 human cancer cell lines treated with DMSO or AZD5153 for 24h to determine compound mechanism of action Measured mRNA levels in cell lines treated with either AZD5153 or DMSO for 24h

2016-08-20 | E-GEOD-85840 | biostudies-arrayexpress

Gene expression profiles of the mammary gland tumors from Nr1d1+/+;PyMT and Nr1d1-/-;PyMT mice

Project description:To investigate the role of NR1D1 in the progression of breast cancer, mammary gland tumor tissues were obtained from 14 weeks old FVB Nr1d1+/+;PyMT and Nr1d1-/-;PyMT mice and the gene expression patterns were analyzed by RNA-seq.

2023-06-27 | GSE222645 | GEO

ATAC-seq for LuCaP145.2 tumors treated with 50 mg/kg JQ1 or 10 mg/kg AZD5153 for 7 days

Project description:ATAC-seq for LuCaP145.2 tumors treated with 50 mg/kg JQ1 or 10 mg/kg AZD5153 for 7 days

| PRJNA1104154 | ENA

Transcriptional changes induced by Brd4 inhibitor, AZD5153, in cancer cell lines

Project description:We sequenced mRNA from 12 human cancer cell lines treated with DMSO or AZD5153 for 24h to determine compound mechanism of action

2016-08-20 | GSE85840 | GEO

Transcriptomic changes following NR1D1 modulation in thyroid cancer cell lines

Project description:Nuclear receptor subfamily 1 group D member 1 (NR1D1), also known as Rev-Erbα, is a circadian clock component that functions as a transcriptional repressor which coordinates circadian rhythm and cell metabolism. Altered circadian clock characteristics have been shown in malignant thyroid neoplasms, and NR1D1 is one of the recurrence-associated genes in papillary thyroid cancer. We aimed to investigate the biological role of NR1D1 in thyroid cancer cells.

2024-02-22 | GSE255015 | GEO

Transcriptomic profiling of MLL-r AML PDX cells treated with CDKI-73 and/or JQ1

Project description:Transcriptomic profiling of MLL-r AML PDX cells treated with CDKI-73 and/or JQ1

2020-02-03 | GSE129449 | GEO